Centre’s COVID-19 vaccination drive will lead to profiteering by private companies: Forum

By: |
April 22, 2021 11:27 AM

A national association of doctors and scientists have accused the Centre of lending the COVID-19 vaccination drive to "profiteering" by private companies rather than ensuring public financing of the programme.

MoHFW refuted reports that as SII had contracted all its production to the Centre till May 25, the states would not be able to procure vaccines from it. The new vaccine policy comes into force from May 1.MoHFW refuted reports that as SII had contracted all its production to the Centre till May 25, the states would not be able to procure vaccines from it. The new vaccine policy comes into force from May 1.

A national association of doctors and scientists have accused the Centre of lending the COVID-19 vaccination drive to “profiteering” by private companies rather than ensuring public financing of the programme. In a statement, the Progressive Medicos and Scientists Forum, said on Wednesday that the Centre’s move is “bound to lend the vaccine prices to market manipulation for maximising private profits”.

“Rather than ensuring entirely public financing of vaccination, which makes far better epidemiological and economic sense, the government has lent even the vaccination drive to profiteering by private companies by announcing that 50 per cent of all the doses shall now be routed through open market.

“This is bound to lend the vaccine prices to all manner market manipulation for maximising private profits. Promises of free vaccination, it appears, are good only for winning elections, and dumping the people thereafter,” it said. The forum said the central government commands the financial resources to extend grants to, and thereby demand answerability of private manufacturers.

“In a situation where there is already a critical shortage of vaccine doses, this implies that the states shall have to bargain at their level with the manufacturers for the best price, and shall in (all) probability have to out-bid each other to be able to secure enough doses to meet their respective demands.

“The situation demanded of the Centre to procure vaccine supplies at a much reasonable cost through public sector and extend liberal grants to the states,” it added. The Centre had on Monday announced that everyone above the 18 years of age would be eligible to get vaccinated against COVID-19 from May 1. It also allowed states, private hospitals and industrial establishments to procure the vaccine doses directly from manufacturers.

Under the third phase of the national vaccination drive commencing next month, the vaccine manufacturers would supply 50 per cent of their monthly Central Drugs Laboratory (CDL) released doses to the central government. They would be free to supply the remaining 50 per cent doses to state governments and in the open market.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19: Vaccine supplies to get a leg-up, says govt
2BIBCOL to manufacture 2 crore doses of Covaxin every month in UP
3India may soon allow Covid-19 jab for pregnant women, but where are the vaccine stocks?